Our flagship products
Cartexan®
A prescription drug, financed by Social Security, registered in Spain by the Spanish Agency of Medicines and Medical Devices (AEMPS). It is also approved in other countries. Please contact us for more information. Cartexan® is indicated for symptomatic osteoarthritis treatment. It contains chondroitin sulphate as an active substance, in boxes with 60, 400-mg hard gelatin capsules. The recommended dose is 2 capsules per day, preferably taken at one time, for at least 3 months.
Droglican®
A prescription drug, financed by Social Security, registered in Spain by the Spanish Agency of Medicines and Medical Devices (AEMPS). It is indicated for the symptomatic treatment of osteoarthritis of the knee in patients with moderate to severe pain for whom the combined treatment with chondroitin sulphate and glucosamine is indicated. Contains chondroitin sulphate and glucosamine hydrochloride as active substances and comes in boxes with 90 hard gelatin capsules which contain 200 mg of chondroitin sulphate and 250 mg of glucosamine hydrochloride each. The therapeutic dose is 6 capsules per day, and it is recommended to take 2 capsules, 3 times per day, to complete this dose, for at least 6 months.